HeadInvest LLC’s Repligen RGEN Stock Holding History

HeadInvest LLC’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$1.55K	–	584
2023 Q3	$1.55K	Buy	+10	New	+$1.64K	﹤0.01%	691

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HeadInvest LLC's RGEN Position: Q4 2023 in Review

HeadInvest LLC sold out of Repligen (RGEN) in Q4 2023, closing a stake of 10 shares — an estimated $1.55K sold.

HeadInvest LLC first reported a position in RGEN in Q3 2023 and held it in 1 quarter. The position peaked at $1.55K in Q3 2023. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

HeadInvest LLC reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 10 Repligen shares in Q4 2023, an estimated $1.55K.
HeadInvest LLC first reported a position in Repligen in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's Repligen position peaked at $1.55K in Q3 2023.
466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.